nodes	percent_of_prediction	percent_of_DWPC	metapath
Bopindolol—Carvedilol—hypertension	0.216	0.678	CrCtD
Bopindolol—Propranolol—hypertension	0.103	0.322	CrCtD
Bopindolol—HTR1B—hypertension	0.0592	0.38	CbGaD
Bopindolol—ADRB1—hypertension	0.0523	0.337	CbGaD
Bopindolol—ADRB2—hypertension	0.044	0.283	CbGaD
Bopindolol—Carteolol—Nadolol—hypertension	0.0212	0.0966	CrCrCtD
Bopindolol—ADRB3—Nadolol—hypertension	0.0184	0.0697	CbGbCtD
Bopindolol—ADRB3—Labetalol—hypertension	0.0184	0.0697	CbGbCtD
Bopindolol—ADRB3—Pindolol—hypertension	0.0157	0.0593	CbGbCtD
Bopindolol—Carteolol—Pindolol—hypertension	0.0157	0.0714	CrCrCtD
Bopindolol—Carteolol—Penbutolol—hypertension	0.0153	0.0698	CrCrCtD
Bopindolol—Bupranolol—Nadolol—hypertension	0.0153	0.0698	CrCrCtD
Bopindolol—Bupranolol—Timolol—hypertension	0.013	0.0594	CrCrCtD
Bopindolol—Bupranolol—Pindolol—hypertension	0.0113	0.0516	CrCrCtD
Bopindolol—Bupranolol—Penbutolol—hypertension	0.0111	0.0505	CrCrCtD
Bopindolol—ADRB2—Esmolol—hypertension	0.00994	0.0376	CbGbCtD
Bopindolol—ADRB1—Esmolol—hypertension	0.00979	0.0371	CbGbCtD
Bopindolol—Propafenone—Carvedilol—hypertension	0.0097	0.0443	CrCrCtD
Bopindolol—Carteolol—Propranolol—hypertension	0.00958	0.0437	CrCrCtD
Bopindolol—ADRB3—Timolol—hypertension	0.009	0.0341	CbGbCtD
Bopindolol—Carvedilol—Propranolol—hypertension	0.00872	0.0398	CrCrCtD
Bopindolol—ADRB3—Carvedilol—hypertension	0.00871	0.033	CbGbCtD
Bopindolol—HTR1B—Pindolol—hypertension	0.00806	0.0305	CbGbCtD
Bopindolol—ADRB3—Propranolol—hypertension	0.00802	0.0304	CbGbCtD
Bopindolol—Propafenone—Quinapril—hypertension	0.00771	0.0352	CrCrCtD
Bopindolol—Propafenone—Esmolol—hypertension	0.00771	0.0352	CrCrCtD
Bopindolol—ADRB2—Labetalol—hypertension	0.00753	0.0285	CbGbCtD
Bopindolol—ADRB2—Nebivolol—hypertension	0.00753	0.0285	CbGbCtD
Bopindolol—ADRB2—Nadolol—hypertension	0.00753	0.0285	CbGbCtD
Bopindolol—Propafenone—Benazepril—hypertension	0.00752	0.0343	CrCrCtD
Bopindolol—ADRB1—Nebivolol—hypertension	0.00742	0.0281	CbGbCtD
Bopindolol—ADRB1—Labetalol—hypertension	0.00742	0.0281	CbGbCtD
Bopindolol—ADRB1—Nadolol—hypertension	0.00742	0.0281	CbGbCtD
Bopindolol—Propranolol—Carvedilol—hypertension	0.00721	0.0329	CrCrCtD
Bopindolol—ADRB2—Acebutolol—hypertension	0.00689	0.0261	CbGbCtD
Bopindolol—ADRB1—Acebutolol—hypertension	0.00679	0.0257	CbGbCtD
Bopindolol—Propafenone—Labetalol—hypertension	0.00666	0.0304	CrCrCtD
Bopindolol—Propranolol—Acebutolol—hypertension	0.00665	0.0303	CrCrCtD
Bopindolol—HTR1B—Penbutolol—hypertension	0.00657	0.0249	CbGbCtD
Bopindolol—ADRB2—Metoprolol—hypertension	0.00641	0.0242	CbGbCtD
Bopindolol—ADRB2—Pindolol—hypertension	0.00641	0.0242	CbGbCtD
Bopindolol—ADRB1—Metoprolol—hypertension	0.00631	0.0239	CbGbCtD
Bopindolol—ADRB1—Pindolol—hypertension	0.00631	0.0239	CbGbCtD
Bopindolol—Propranolol—Metoprolol—hypertension	0.00604	0.0276	CrCrCtD
Bopindolol—HTR1A—Nebivolol—hypertension	0.00594	0.0225	CbGbCtD
Bopindolol—Propranolol—Esmolol—hypertension	0.00572	0.0261	CrCrCtD
Bopindolol—ADRB2—Betaxolol—hypertension	0.00571	0.0216	CbGbCtD
Bopindolol—ADRB1—Betaxolol—hypertension	0.00562	0.0213	CbGbCtD
Bopindolol—Propranolol—Pindolol—hypertension	0.00559	0.0255	CrCrCtD
Bopindolol—Ketoprofen—Labetalol—hypertension	0.00557	0.0254	CrCrCtD
Bopindolol—Propranolol—Penbutolol—hypertension	0.00546	0.0249	CrCrCtD
Bopindolol—ADRB2—Penbutolol—hypertension	0.00522	0.0198	CbGbCtD
Bopindolol—ADRB1—Penbutolol—hypertension	0.00514	0.0195	CbGbCtD
Bopindolol—HTR1A—Pindolol—hypertension	0.00505	0.0191	CbGbCtD
Bopindolol—Propranolol—Betaxolol—hypertension	0.00504	0.023	CrCrCtD
Bopindolol—Propafenone—Propranolol—hypertension	0.0046	0.021	CrCrCtD
Bopindolol—HTR1B—Propranolol—hypertension	0.00413	0.0156	CbGbCtD
Bopindolol—HTR1A—Penbutolol—hypertension	0.00412	0.0156	CbGbCtD
Bopindolol—ADRB2—Timolol—hypertension	0.00368	0.0139	CbGbCtD
Bopindolol—ADRB1—Timolol—hypertension	0.00362	0.0137	CbGbCtD
Bopindolol—ADRB2—Carvedilol—hypertension	0.00356	0.0135	CbGbCtD
Bopindolol—Benzyl Benzoate—Bepridil—hypertension	0.00352	0.0161	CrCrCtD
Bopindolol—ADRB1—Carvedilol—hypertension	0.00351	0.0133	CbGbCtD
Bopindolol—Benzyl Benzoate—Benazepril—hypertension	0.00335	0.0153	CrCrCtD
Bopindolol—ADRB2—Propranolol—hypertension	0.00328	0.0124	CbGbCtD
Bopindolol—HTR1A—Prazosin—hypertension	0.00325	0.0123	CbGbCtD
Bopindolol—ADRB1—Propranolol—hypertension	0.00323	0.0122	CbGbCtD
Bopindolol—HTR1A—Propranolol—hypertension	0.00259	0.00978	CbGbCtD
Bopindolol—ADRB2—Treprostinil—Nadolol—hypertension	0.000497	1	CbGdCrCtD
Bopindolol—Carvedilol—NPPB—hypertension	0.000162	0.0946	CrCbGaD
Bopindolol—Carvedilol—GJA1—hypertension	0.000162	0.0946	CrCbGaD
Bopindolol—Carvedilol—SELE—hypertension	0.000154	0.0897	CrCbGaD
Bopindolol—Carvedilol—VCAM1—hypertension	0.000147	0.0856	CrCbGaD
Bopindolol—Carvedilol—HIF1A—hypertension	0.000123	0.0717	CrCbGaD
Bopindolol—Carteolol—ADRB1—hypertension	8.23e-05	0.0481	CrCbGaD
Bopindolol—Carvedilol—ADRA2B—hypertension	7.56e-05	0.0442	CrCbGaD
Bopindolol—Carvedilol—XDH—hypertension	7.16e-05	0.0418	CrCbGaD
Bopindolol—Bupranolol—ADRB1—hypertension	7e-05	0.0409	CrCbGaD
Bopindolol—Carteolol—ADRB2—hypertension	6.92e-05	0.0404	CrCbGaD
Bopindolol—Bupranolol—ADRB2—hypertension	5.89e-05	0.0344	CrCbGaD
Bopindolol—Carvedilol—VEGFA—hypertension	4.95e-05	0.0289	CrCbGaD
Bopindolol—Mebendazole—CYP1A1—hypertension	4.84e-05	0.0283	CrCbGaD
Bopindolol—Carvedilol—ADRA1A—hypertension	4.68e-05	0.0273	CrCbGaD
Bopindolol—Ketoprofen—CXCL8—hypertension	4.49e-05	0.0262	CrCbGaD
Bopindolol—Propafenone—ADRB1—hypertension	3.68e-05	0.0215	CrCbGaD
Bopindolol—Carvedilol—ADRA2A—hypertension	3.31e-05	0.0194	CrCbGaD
Bopindolol—Carvedilol—ADRB1—hypertension	3.31e-05	0.0193	CrCbGaD
Bopindolol—Propranolol—HTR1B—hypertension	2.85e-05	0.0166	CrCbGaD
Bopindolol—Carvedilol—ADRB2—hypertension	2.78e-05	0.0163	CrCbGaD
Bopindolol—Propranolol—CYP3A5—hypertension	2.68e-05	0.0156	CrCbGaD
Bopindolol—Carvedilol—PTGS1—hypertension	2.61e-05	0.0152	CrCbGaD
Bopindolol—Propranolol—ADRB1—hypertension	2.52e-05	0.0147	CrCbGaD
Bopindolol—Carvedilol—CYP1A1—hypertension	2.39e-05	0.0139	CrCbGaD
Bopindolol—Ketoprofen—PTGS1—hypertension	2.29e-05	0.0134	CrCbGaD
Bopindolol—Propranolol—ADRB2—hypertension	2.12e-05	0.0124	CrCbGaD
Bopindolol—Propranolol—CYP1A1—hypertension	1.82e-05	0.0106	CrCbGaD
Bopindolol—Ketoprofen—PTGS2—hypertension	1.31e-05	0.00764	CrCbGaD
Bopindolol—Ketoprofen—ALB—hypertension	1.17e-05	0.00681	CrCbGaD
Bopindolol—HTR1B—artery—hypertension	5.03e-06	0.151	CbGeAlD
Bopindolol—HTR1B—blood vessel—hypertension	3.92e-06	0.117	CbGeAlD
Bopindolol—ADRB1—cardiac ventricle—hypertension	2.66e-06	0.0795	CbGeAlD
Bopindolol—ADRB1—myocardium—hypertension	2.5e-06	0.0748	CbGeAlD
Bopindolol—HTR1B—brainstem—hypertension	2.14e-06	0.0641	CbGeAlD
Bopindolol—HTR1B—cardiovascular system—hypertension	1.75e-06	0.0523	CbGeAlD
Bopindolol—ADRB1—heart—hypertension	1.74e-06	0.0522	CbGeAlD
Bopindolol—HTR1A—brainstem—hypertension	1.73e-06	0.0518	CbGeAlD
Bopindolol—ADRB1—cardiovascular system—hypertension	1.65e-06	0.0492	CbGeAlD
Bopindolol—HTR1A—Signaling Pathways—AVP—hypertension	1.52e-06	3.82e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—KDR—hypertension	1.51e-06	3.8e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—EDN1—hypertension	1.51e-06	3.8e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—RHOA—hypertension	1.51e-06	3.79e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—APOB—hypertension	1.5e-06	3.77e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—GNAS—hypertension	1.5e-06	3.77e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—CCL5—hypertension	1.5e-06	3.77e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—PTK2—hypertension	1.5e-06	3.76e-05	CbGpPWpGaD
Bopindolol—ADRB1—cardiac atrium—hypertension	1.49e-06	0.0446	CbGeAlD
Bopindolol—HTR1A—Signaling by GPCR—PIK3R1—hypertension	1.49e-06	3.75e-05	CbGpPWpGaD
Bopindolol—ADRB2—GPCR downstream signaling—CXCL8—hypertension	1.49e-06	3.74e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—EDN1—hypertension	1.48e-06	3.71e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—APOB—hypertension	1.47e-06	3.69e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—CCL5—hypertension	1.47e-06	3.69e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—LPL—hypertension	1.47e-06	3.68e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—PTK2—hypertension	1.46e-06	3.68e-05	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—RELA—hypertension	1.46e-06	3.67e-05	CbGpPWpGaD
Bopindolol—HTR1A—GPCR downstream signaling—CXCL8—hypertension	1.46e-06	3.66e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—H2AFX—hypertension	1.45e-06	3.66e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—F2—hypertension	1.45e-06	3.66e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—PRKCB—hypertension	1.45e-06	3.66e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—FN1—hypertension	1.45e-06	3.66e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—PDGFRB—hypertension	1.45e-06	3.65e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—RPS6KB1—hypertension	1.45e-06	3.65e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—EDN1—hypertension	1.44e-06	3.63e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—ADCY5—hypertension	1.43e-06	3.61e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—CCL5—hypertension	1.43e-06	3.6e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—LPL—hypertension	1.43e-06	3.6e-05	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—MTOR—hypertension	1.43e-06	3.6e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—PRKCG—hypertension	1.42e-06	3.58e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—NOTCH1—hypertension	1.42e-06	3.58e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—H2AFX—hypertension	1.42e-06	3.58e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—RPS6KB1—hypertension	1.42e-06	3.57e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—PDGFRB—hypertension	1.42e-06	3.57e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—PRKCA—hypertension	1.42e-06	3.56e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—ITGB3—hypertension	1.42e-06	3.56e-05	CbGpPWpGaD
Bopindolol—HTR1A—cardiovascular system—hypertension	1.41e-06	0.0422	CbGeAlD
Bopindolol—ADRB1—Signaling Pathways—YWHAZ—hypertension	1.4e-06	3.53e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—ADCY5—hypertension	1.4e-06	3.53e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—LPL—hypertension	1.4e-06	3.52e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—PRKCG—hypertension	1.39e-06	3.5e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—H2AFX—hypertension	1.39e-06	3.5e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—PDGFRB—hypertension	1.39e-06	3.49e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—RPS6KB1—hypertension	1.39e-06	3.49e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—SPP1—hypertension	1.39e-06	3.49e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—NGF—hypertension	1.39e-06	3.49e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—PRKCA—hypertension	1.38e-06	3.48e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—ITGB3—hypertension	1.38e-06	3.48e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—CXCL8—hypertension	1.38e-06	3.47e-05	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—CXCL8—hypertension	1.38e-06	3.46e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—YWHAZ—hypertension	1.37e-06	3.45e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—ADCY5—hypertension	1.37e-06	3.45e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—PRKCG—hypertension	1.36e-06	3.43e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—NGF—hypertension	1.36e-06	3.41e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—SPP1—hypertension	1.36e-06	3.41e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—PRKCA—hypertension	1.35e-06	3.4e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—ITGB3—hypertension	1.35e-06	3.4e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—CXCL8—hypertension	1.35e-06	3.4e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—PRKCD—hypertension	1.35e-06	3.39e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—CCR5—hypertension	1.35e-06	3.39e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—YWHAZ—hypertension	1.34e-06	3.38e-05	CbGpPWpGaD
Bopindolol—ADRB3—GPCR downstream signaling—AKT1—hypertension	1.33e-06	3.34e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—NGF—hypertension	1.33e-06	3.34e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—SPP1—hypertension	1.33e-06	3.34e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—POMC—hypertension	1.32e-06	3.33e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—CXCL8—hypertension	1.32e-06	3.32e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—HTR2A—hypertension	1.32e-06	3.32e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—CCR5—hypertension	1.32e-06	3.32e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—PRKCD—hypertension	1.32e-06	3.32e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—C3—hypertension	1.32e-06	3.32e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—INS—hypertension	1.32e-06	3.31e-05	CbGpPWpGaD
Bopindolol—ADRB3—Signaling by GPCR—IL6—hypertension	1.31e-06	3.29e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—CCL2—hypertension	1.3e-06	3.26e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—HTR2A—hypertension	1.29e-06	3.25e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—PRKCD—hypertension	1.29e-06	3.25e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—CCR5—hypertension	1.29e-06	3.25e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—C3—hypertension	1.29e-06	3.24e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—PDGFB—hypertension	1.28e-06	3.23e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—FGFR1—hypertension	1.28e-06	3.21e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—IGF1—hypertension	1.27e-06	3.2e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—AKT2—hypertension	1.27e-06	3.2e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—EGFR—hypertension	1.27e-06	3.19e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—HTR2A—hypertension	1.26e-06	3.18e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—C3—hypertension	1.26e-06	3.17e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—HIF1A—hypertension	1.26e-06	3.16e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—PDGFB—hypertension	1.26e-06	3.16e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—AGT—hypertension	1.25e-06	3.15e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—FGFR1—hypertension	1.25e-06	3.14e-05	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—MMP9—hypertension	1.24e-06	3.13e-05	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—CDKN1A—hypertension	1.24e-06	3.12e-05	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—PTEN—hypertension	1.24e-06	3.11e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—CALM1—hypertension	1.23e-06	3.1e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—HIF1A—hypertension	1.23e-06	3.09e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—PDGFB—hypertension	1.23e-06	3.09e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—LEP—hypertension	1.23e-06	3.09e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—APOE—hypertension	1.23e-06	3.09e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—AGT—hypertension	1.23e-06	3.08e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—FGFR1—hypertension	1.22e-06	3.07e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—CAV1—hypertension	1.22e-06	3.06e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—APOA1—hypertension	1.21e-06	3.05e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—SERPINE1—hypertension	1.21e-06	3.04e-05	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—MAPK8—hypertension	1.21e-06	3.04e-05	CbGpPWpGaD
Bopindolol—ADRB3—Signaling by GPCR—AKT1—hypertension	1.21e-06	3.03e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—CALM1—hypertension	1.21e-06	3.03e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—HIF1A—hypertension	1.2e-06	3.03e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—KDR—hypertension	1.2e-06	3.03e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—LEP—hypertension	1.2e-06	3.02e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—APOE—hypertension	1.2e-06	3.02e-05	CbGpPWpGaD
Bopindolol—HTR1B—endocrine gland—hypertension	1.2e-06	0.0359	CbGeAlD
Bopindolol—HTR1A—Signaling Pathways—AGT—hypertension	1.2e-06	3.01e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—CAV1—hypertension	1.19e-06	2.99e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—APOA1—hypertension	1.19e-06	2.99e-05	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—EP300—hypertension	1.18e-06	2.97e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—CALM1—hypertension	1.18e-06	2.96e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—KDR—hypertension	1.18e-06	2.96e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—APOE—hypertension	1.17e-06	2.95e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—LEP—hypertension	1.17e-06	2.95e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—FGF2—hypertension	1.17e-06	2.95e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—RHOA—hypertension	1.17e-06	2.94e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—CAV1—hypertension	1.16e-06	2.93e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—APOA1—hypertension	1.16e-06	2.92e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—FN1—hypertension	1.16e-06	2.91e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—PRKCB—hypertension	1.16e-06	2.91e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—F2—hypertension	1.16e-06	2.91e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—PIK3R1—hypertension	1.16e-06	2.91e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—NOS3—hypertension	1.16e-06	2.91e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—KDR—hypertension	1.15e-06	2.89e-05	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—SRC—hypertension	1.15e-06	2.88e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—NOTCH1—hypertension	1.13e-06	2.85e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—FN1—hypertension	1.13e-06	2.85e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—F2—hypertension	1.13e-06	2.85e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—PRKCB—hypertension	1.13e-06	2.85e-05	CbGpPWpGaD
Bopindolol—ADRB1—endocrine gland—hypertension	1.13e-06	0.0338	CbGeAlD
Bopindolol—ADRB3—Signaling Pathways—VEGFA—hypertension	1.12e-06	2.81e-05	CbGpPWpGaD
Bopindolol—HTR1A—adrenal gland—hypertension	1.12e-06	0.0334	CbGeAlD
Bopindolol—ADRB2—Signaling Pathways—NOTCH1—hypertension	1.11e-06	2.79e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—F2—hypertension	1.11e-06	2.79e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—FN1—hypertension	1.11e-06	2.79e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—PRKCB—hypertension	1.11e-06	2.79e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—RELA—hypertension	1.09e-06	2.73e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—NOTCH1—hypertension	1.08e-06	2.73e-05	CbGpPWpGaD
Bopindolol—HTR1B—central nervous system—hypertension	1.08e-06	0.0324	CbGeAlD
Bopindolol—HTR1B—Signaling Pathways—MTOR—hypertension	1.07e-06	2.68e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—POMC—hypertension	1.06e-06	2.65e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—INS—hypertension	1.05e-06	2.64e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—CCL2—hypertension	1.03e-06	2.6e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—POMC—hypertension	1.03e-06	2.6e-05	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—MYC—hypertension	1.03e-06	2.58e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—INS—hypertension	1.03e-06	2.58e-05	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—TGFB1—hypertension	1.03e-06	2.58e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—CXCL8—hypertension	1.02e-06	2.58e-05	CbGpPWpGaD
Bopindolol—ADRB1—central nervous system—hypertension	1.02e-06	0.0304	CbGeAlD
Bopindolol—ADRB1—Signaling Pathways—IGF1—hypertension	1.01e-06	2.55e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—AKT2—hypertension	1.01e-06	2.55e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—EGFR—hypertension	1.01e-06	2.54e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—CCL2—hypertension	1.01e-06	2.54e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—POMC—hypertension	1.01e-06	2.54e-05	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—EGFR—hypertension	1.01e-06	2.53e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—INS—hypertension	1e-06	2.52e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—IGF1—hypertension	9.93e-07	2.5e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—AKT2—hypertension	9.92e-07	2.49e-05	CbGpPWpGaD
Bopindolol—HTR1B—GPCR downstream signaling—AKT1—hypertension	9.9e-07	2.49e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—EGFR—hypertension	9.88e-07	2.48e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—CCL2—hypertension	9.87e-07	2.48e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—IL6—hypertension	9.75e-07	2.45e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—IGF1—hypertension	9.71e-07	2.44e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—AKT2—hypertension	9.7e-07	2.44e-05	CbGpPWpGaD
Bopindolol—HTR1A—endocrine gland—hypertension	9.68e-07	0.029	CbGeAlD
Bopindolol—HTR1A—Signaling by GPCR—EGFR—hypertension	9.66e-07	2.43e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—SERPINE1—hypertension	9.64e-07	2.42e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—SERPINE1—hypertension	9.43e-07	2.37e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—FGF2—hypertension	9.33e-07	2.35e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—RHOA—hypertension	9.3e-07	2.34e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—MMP9—hypertension	9.27e-07	2.33e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—CDKN1A—hypertension	9.24e-07	2.32e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—SERPINE1—hypertension	9.22e-07	2.32e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—PTEN—hypertension	9.22e-07	2.32e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—NOS3—hypertension	9.2e-07	2.31e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—PIK3R1—hypertension	9.2e-07	2.31e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—FGF2—hypertension	9.13e-07	2.29e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—RHOA—hypertension	9.1e-07	2.29e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—MAPK8—hypertension	9.02e-07	2.27e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—NOS3—hypertension	9e-07	2.26e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—PIK3R1—hypertension	9e-07	2.26e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—AKT1—hypertension	8.99e-07	2.26e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—FGF2—hypertension	8.92e-07	2.24e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—RHOA—hypertension	8.89e-07	2.24e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—NOS3—hypertension	8.8e-07	2.21e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—PIK3R1—hypertension	8.8e-07	2.21e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—EP300—hypertension	8.79e-07	2.21e-05	CbGpPWpGaD
Bopindolol—HTR1A—central nervous system—hypertension	8.72e-07	0.0261	CbGeAlD
Bopindolol—ADRB1—Signaling Pathways—RELA—hypertension	8.66e-07	2.18e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—SRC—hypertension	8.55e-07	2.15e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—MTOR—hypertension	8.49e-07	2.14e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—RELA—hypertension	8.47e-07	2.13e-05	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—TP53—hypertension	8.44e-07	2.12e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—VEGFA—hypertension	8.32e-07	2.09e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—MTOR—hypertension	8.31e-07	2.09e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—RELA—hypertension	8.28e-07	2.08e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—CXCL8—hypertension	8.16e-07	2.05e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—MTOR—hypertension	8.12e-07	2.04e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—CXCL8—hypertension	7.98e-07	2.01e-05	CbGpPWpGaD
Bopindolol—ADRB1—GPCR downstream signaling—AKT1—hypertension	7.88e-07	1.98e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—CXCL8—hypertension	7.81e-07	1.96e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—IL6—hypertension	7.76e-07	1.95e-05	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—IL6—hypertension	7.72e-07	1.94e-05	CbGpPWpGaD
Bopindolol—ADRB2—GPCR downstream signaling—AKT1—hypertension	7.71e-07	1.94e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—MYC—hypertension	7.66e-07	1.93e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—TGFB1—hypertension	7.64e-07	1.92e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—IL6—hypertension	7.59e-07	1.91e-05	CbGpPWpGaD
Bopindolol—HTR1A—GPCR downstream signaling—AKT1—hypertension	7.54e-07	1.9e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—EGFR—hypertension	7.49e-07	1.88e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—IL6—hypertension	7.42e-07	1.87e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—MMP9—hypertension	7.38e-07	1.86e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—CDKN1A—hypertension	7.36e-07	1.85e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—PTEN—hypertension	7.34e-07	1.85e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—MMP9—hypertension	7.22e-07	1.82e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—CDKN1A—hypertension	7.2e-07	1.81e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—MAPK8—hypertension	7.18e-07	1.81e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—PTEN—hypertension	7.18e-07	1.81e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—AKT1—hypertension	7.16e-07	1.8e-05	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—AKT1—hypertension	7.13e-07	1.79e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—MMP9—hypertension	7.06e-07	1.78e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—CDKN1A—hypertension	7.04e-07	1.77e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—MAPK8—hypertension	7.02e-07	1.77e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—PTEN—hypertension	7.02e-07	1.77e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—AKT1—hypertension	7e-07	1.76e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—EP300—hypertension	7e-07	1.76e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—MAPK8—hypertension	6.87e-07	1.73e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—AKT1—hypertension	6.85e-07	1.72e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—EP300—hypertension	6.85e-07	1.72e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—SRC—hypertension	6.81e-07	1.71e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—EP300—hypertension	6.7e-07	1.68e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—SRC—hypertension	6.66e-07	1.67e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—VEGFA—hypertension	6.63e-07	1.67e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—SRC—hypertension	6.51e-07	1.64e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—VEGFA—hypertension	6.48e-07	1.63e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—VEGFA—hypertension	6.34e-07	1.59e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—TP53—hypertension	6.29e-07	1.58e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—MYC—hypertension	6.1e-07	1.53e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—TGFB1—hypertension	6.08e-07	1.53e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—MYC—hypertension	5.97e-07	1.5e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—EGFR—hypertension	5.97e-07	1.5e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—TGFB1—hypertension	5.95e-07	1.5e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—EGFR—hypertension	5.84e-07	1.47e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—MYC—hypertension	5.83e-07	1.47e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—TGFB1—hypertension	5.82e-07	1.46e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—IL6—hypertension	5.76e-07	1.45e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—EGFR—hypertension	5.71e-07	1.43e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—AKT1—hypertension	5.31e-07	1.34e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—TP53—hypertension	5.01e-07	1.26e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—TP53—hypertension	4.9e-07	1.23e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—TP53—hypertension	4.79e-07	1.2e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—IL6—hypertension	4.58e-07	1.15e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—IL6—hypertension	4.49e-07	1.13e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—IL6—hypertension	4.39e-07	1.1e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—AKT1—hypertension	4.23e-07	1.06e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—AKT1—hypertension	4.14e-07	1.04e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—AKT1—hypertension	4.05e-07	1.02e-05	CbGpPWpGaD
